William Kapp, MD, President and Co-founder of Fountain Life explains why the short answer is yes – but it’s all about the right data. Artificial intelligence (AI) technologies present a broad array of opportunities to improve healthcare across the care continuum, including longevity. Increasing lifespan has long been an interest for researchers and healthcare professionals, […]

The clinical stage biopharma Anebulo Pharmaceuticals recently shared that it received positive FDA feedback after a Type B meeting in July, where the regulatory agency indicated a path to approval for ANEB-001, a competitive CB1 antagonist with a high affinity for the human CB1 receptor. Overstimulation of this receptor by cannabinoids such as THC causes […]

Glioblastoma (GBM) remains a difficult malignancy to treat, despite countless clinical trials that have introduced new therapies for patients with the disease, according to John de Groot, MD and Patrick Y. Wen, MD. However, targeting a novel mechanism of action could be the answer to improving the survival rates for these patients. The treatment modalities […]